• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. CLARIA MRI QUAD CRT-D SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. CLARIA MRI QUAD CRT-D SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTMA1Q1
Device Problems Failure to Deliver Shock/Stimulation (1133); Device Sensing Problem (2917)
Patient Problem Tachycardia (2095)
Event Date 03/03/2024
Event Type  Injury  
Manufacturer Narrative
Continuation of d10:  (b)(6) tissue valve implanted (b)(6) 2016; 694758 lead implanted (b)(6)2012; 5076-52 lead implanted (b)(6) 2008.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
It was reported that the patient was symptomatic.Upon review it was noted that the cardiac resynchronization therapy defibrillator (crt-d) inappropriately withheld therapy for ventricular tachycardia (vt) episodes which were classified as supra ventricular tachycardia (svt) via the device feature that compares the patient¿s current qrs waveform to a collected and stored template of the patient¿s qrs waveform during sinus rhythm.It was also noted that the physician thought the device was classifying episodes as terminated when the events did not appear to be truly terminated clinically. the device is still in use.  no further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Correction: b2; b5; e1-3; g2; imf (annex f) health impact code.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
It was reported that the patient was symptomatic.Upon review it was noted that the cardiac resynchronization therapy defibrillator (crt-d) inappropriately withheld therapy for ventricular tachycardia (vt) episodes which were classified as supra ventricular tachycardia (svt) via the device feature that compares the patient¿s current qrs waveform to a collected and stored template of the patient¿s qrs waveform during sinus rhythm.It was also noted that the physician thought the device was classifying episodes as terminated when the events did not appear to be truly terminated clinically. the device is still in use. no further patient complications have been reported as a result of this event.It was additionally reported that the device feature was programmed off.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLARIA MRI QUAD CRT-D SURESCAN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key19000004
MDR Text Key338878996
Report Number3004209178-2024-08067
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00643169705760
UDI-Public00643169705760
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/28/2018
Device Model NumberDTMA1Q1
Device Catalogue NumberDTMA1Q1
Was Device Available for Evaluation? No
Date Manufacturer Received03/05/2024
Date Device Manufactured11/29/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
479888 LEAD
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age73 YR
Patient SexMale
-
-